Stocktoria
Edgewise Therapeutics, Inc. EWTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Chart by TradingView
1/9
Piotroski F — financial health
18.65
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$191.4M | -$158.8M | -$114.4M | -$71.7M | -$43.2M |
| Net income | -$167.8M | -$133.8M | -$100.2M | -$67.6M | -$42.8M |
| Operating cash flow | -$143.8M | -$109.0M | -$91.9M | -$52.6M | -$33.5M |
| Free cash flow | -$144.1M | -$110.3M | -$97.7M | -$58.2M | -$34.2M |
| Total assets | $552.6M | $486.8M | $340.0M | $367.1M | $285.2M |
| Total liabilities | $30.3M | $27.6M | $21.2M | $20.4M | $10.8M |
| Shareholders' equity | $522.3M | $459.2M | $318.8M | $346.7M | $274.4M |
| Ratios | |||||
| Return on assets | -30.4% | -27.5% | -29.5% | -18.4% | -15.0% |
| Return on equity | -32.1% | -29.1% | -31.4% | -19.5% | -15.6% |
| Current ratio | 19.85 | 19.93 | 19.50 | 21.53 | 26.97 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 14,600 | $459,900 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 18.65 (safe)
- Working capital / assets 0.934
- Retained earnings / assets -0.989
- EBIT / assets -0.346
- Equity / liabilities 17.21
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001710072 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.